![\"US](\"https:\/\/www.send2press.com\/wire\/images\/20-0817s2p-UDPHARM-696x522.jpg\")
\nPHOTO CAPTION: Hylafem\u00ae pH releases 200 billion CFUs of Lactobacillus casei (KE-99) and 100 billion CFUs of Lactobacillus gasseri.<\/em><\/p>\n
Introducing Hylafem\u00ae pH, a patented, over-the-counter, probiotic-based vaginal suppository with an easy applicator. Hylafem\u00ae pH effectively addresses symptoms of bacterial vaginosis (BV), urinary tract infections, vaginal bacterial and yeast infections and post-menopausal dryness, with minimal to no side effects.<\/p>\n
\u201cDeveloping new and innovative products is a passion of mine. My focus is on delivering effective alternatives to traditional pharmaceutical therapies. I am inspired by the ever-evolving benefits of microbes in and on our bodies that are being revealed,\u201d said Allison Krebs, CEO, US Pharmaceutical Corporation.<\/p>\n
Hylafem\u00ae pH relies on the power of probiotics to restore the vaginal microbiome to a state of equilibrium. One fast-dissolving probiotic suppository capsule, adhering to the mucosal membrane, lowers pH from 7.0 to 4.5 within 5 minutes after administration. Most over-the-counter oral probiotics may not even reach the vaginal canal, but Hylafem\u00ae pH directly delivers the probiotics necessary to balance and maintain a healthy vaginal microbiome, which may help stimulate the immune response during vaginal infections.<\/p>\n
Easy to self-administer, with none of the potentially dangerous side effects associated with clindamycin, and none of the messiness of metronidazole gels, Hylafem\u00ae pH is affordable, manufactured and produced in FDA-registered facilities, and provides effective relief, in many instances, with one dose in one day.<\/p>\n
NDC 52747-0255-03
\nU.S. Patent No: 6,797,266 and 10,258,567<\/p>\n
OUR EFFECTIVE INGREDIENTS<\/strong><\/p>\n WHAT HYLAFEM\u00ae pH DOES<\/strong><\/p>\n Bacterial Vaginosis (BV) is one of the most common infections in women of reproductive age. BV occurs when there is an imbalance of good vs. harmful bacteria in the vaginal microbiome.<\/p>\n A rise in pH can increase the likelihood of infection. One vaginal suppository repopulates the vagina with lactobacilli<\/em>, the predominant bacteria in healthy women, creating an unfavorable environment for the growth of bacteria including pathogens.<\/p>\n Also recommended for prevention and maintenance of post-menopausal, post-childbirth, post-surgical, chemotherapy, diabetes-related In the U.S., 32 million post-menopausal women seek relief from the chronic pain associated with vaginal dryness, cracking and itching.<\/p>\n Clinical management of BV has made little progress in the past two decades. The first-line antibiotic therapy showed 70 to 80 percent curative rates after four weeks of treatment, however, high rates of recurrence occurred within 12 months, reaching 40 to 50.<\/p>\n SUPERIOR BENEFITS<\/strong><\/p>\n Many products are designed to provide relief for the symptoms associated with BV, UTI and vaginal dryness. But clinical studies show that, unlike Hylafem\u00ae pH, traditional treatments do not directly address the main causal imbalance of the lactobacillus-dominated (healthy) vaginal flora in the vaginal microbiome and therefore recurrence is frequent.<\/p>\n Hylafem\u00ae pH is:<\/strong><\/p>\n Hylafem\u00ae pH can be purchased at https:\/\/bit.ly\/hylafemph<\/a> for $29.95 MSRP.<\/p>\n About US Pharmaceutical Corporation <\/strong><\/p>\n US Pharmaceutical Corporation\u00ae<\/a> is a family-operated pharmaceutical company based in Atlanta, Georgia, with a specialty in patented prescription nutritional supplements and probiotics. We are proud to serve our patients and customers across the USA, under the same ownership, since 1954. Our team has a lifelong commitment to health and well-being, with probiotics being a consistent part of their daily regimen.<\/p>\n When we develop new medications and devices, the first question we ask ourselves is, “What would we like if we were the patient?\u201d That’s how we developed our slogan “Products designed with the patient in mind.” US Pharmaceutical Corporation\u00ae provides product literature, free samples and product vouchers to health-care providers.<\/p>\n Learn more at: https:\/\/www.uspco.com\/product_literature.aspx?pid=436<\/a><\/p>\n Media Only Contact:<\/strong>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\nNancy Wilson
\nOf US Pharmaceutical Corporation
\n+1-770-987-4745 EXT. 176
\nn.wilson@uspco.com
\nweb: https:\/\/uspco.com\/<\/a><\/p>\n
![http:\/\/www.Send2Press.com\/300dpi\/20-0817s2p-UDPHARM-300dpi.jpg<\/a><\/p>\nDisclaimer: These statements have not been evaluated by the FDA. This product is not intended to cure, diagnose, or prevent any disease.<\/p>\n","protected":false},"excerpt":{"rendered":"DECATUR, Ga., Aug. 17, 2020 (SEND2PRESS NEWSWIRE) — US Pharmaceutical Corporation, the probiotic and nutritional supplement company, launches Hylafem pH vaginal suppositories, a unique, patented, homeopathic suppository product which efficaciously tackles recurring women’s vaginal health issues.<\/p>\n","protected":false},"author":9780,"featured_media":62415,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[571,1,123,61,8950,559,956],"tags":[14024,14023,13917,13916,14022],"class_list":["post-62448","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-news","category-business-news","category-georgia-news","category-health-medical-news","category-mature-content","category-products-news","category-womens-interest","tag-boric-acid","tag-hylafem-ph","tag-probiotics","tag-vaginal-microbiome","tag-womens-health","has-post-title","has-post-date","no-post-category","no-post-tag","no-post-comment","has-post-author"],"acf":[],"views":5729,"_links":{"self":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/62448","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/users\/9780"}],"replies":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/comments?post=62448"}],"version-history":[{"count":0,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/62448\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media\/62415"}],"wp:attachment":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media?parent=62448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/categories?post=62448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/tags?post=62448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}](\"http:\/\/www.Send2Press.com\/300dpi\/20-0817s2p-UDPHARM-300dpi.jpg\"){kind=link}